SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Scope & Guideline

Uniting Research and Clinical Practice in Rheumatology

Introduction

Explore the comprehensive scope of SCANDINAVIAN JOURNAL OF RHEUMATOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore SCANDINAVIAN JOURNAL OF RHEUMATOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0300-9742
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1959 to 1962, 1964, from 1972 to 2024
AbbreviationSCAND J RHEUMATOL / Scand. J. Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Scandinavian Journal of Rheumatology focuses on advancing the knowledge and treatment of rheumatic diseases through high-quality research and clinical studies. Its primary aims and scopes encompass a wide range of topics related to rheumatology, emphasizing the need for evidence-based practices and innovative treatment approaches.
  1. Rheumatic Disease Mechanisms:
    The journal extensively covers the underlying mechanisms of various rheumatic diseases, including autoimmune responses, genetic predispositions, and inflammatory pathways.
  2. Clinical Trials and Treatment Efficacy:
    A significant focus is placed on clinical trials evaluating the efficacy and safety of new and existing treatments for rheumatic diseases, including biologics and novel therapeutic agents.
  3. Patient-Centered Research:
    Research that highlights patient-reported outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases is a core area of interest, promoting a holistic approach to treatment.
  4. Innovative Diagnostic Techniques:
    The journal publishes studies on new diagnostic methods, including imaging techniques and biomarkers, aimed at improving the diagnosis and monitoring of rheumatic conditions.
  5. Epidemiological Studies:
    Epidemiological research assessing the prevalence, incidence, and risk factors associated with rheumatic diseases is prominently featured, contributing to a better understanding of these conditions.
  6. Interdisciplinary Approaches:
    The journal encourages interdisciplinary research that integrates perspectives from various fields, including immunology, genetics, and rehabilitation sciences, to enhance the understanding and management of rheumatological disorders.
The Scandinavian Journal of Rheumatology has seen a notable shift towards emerging themes that reflect current trends in rheumatology research. These themes not only enhance the understanding of rheumatic diseases but also align with advancements in medical science and patient care.
  1. Digital Health and Telemedicine:
    There is a growing emphasis on digital health interventions and telemedicine, particularly in the context of managing chronic rheumatic diseases during and post-COVID-19, showcasing the adaptation of healthcare practices.
  2. Personalized Medicine and Biomarkers:
    Research focusing on personalized medicine, including the identification of biomarkers for treatment responses and disease progression, is increasingly highlighted, reflecting a trend towards tailored therapies.
  3. Comorbidities and Multidisciplinary Care:
    Studies examining the impact of comorbidities on rheumatic diseases and the importance of multidisciplinary care approaches are gaining traction, emphasizing the need for comprehensive patient management.
  4. Longitudinal and Real-World Data Studies:
    There is a trend towards the use of longitudinal studies and real-world data analyses to assess treatment outcomes and disease progression in diverse populations, providing valuable insights into long-term management.
  5. Psychosocial Aspects of Rheumatic Diseases:
    Research exploring the psychological and social factors affecting patients with rheumatic diseases is emerging, indicating a shift towards understanding the holistic impact of these conditions on patients' lives.

Declining or Waning

While the Scandinavian Journal of Rheumatology continues to grow in various research areas, certain themes have seen a decline in prominence over recent years. This may indicate evolving interests within the field or shifts towards more impactful research questions.
  1. Traditional Pharmacotherapy:
    Research focusing solely on traditional pharmacotherapy options, such as NSAIDs and corticosteroids, appears to be waning as newer biologic and targeted therapies gain prominence.
  2. Case Reports and Isolated Incidents:
    The publication of individual case reports has decreased, possibly due to a shift towards larger cohort studies and clinical trials that provide more generalized data and insights.
  3. Basic Science and Laboratory Studies:
    There seems to be a decline in purely laboratory-based studies that do not directly translate into clinical practice, as the journal emphasizes translational research that bridges the gap between laboratory findings and patient care.

Similar Journals

JOURNAL OF RHEUMATOLOGY

Leading the Way in Rheumatology and Immunology Advancements
Publisher: J RHEUMATOL PUBL COISSN: 0315-162XFrequency: 12 issues/year

JOURNAL OF RHEUMATOLOGY, published by the J Rheumatol Publ Co, stands as a distinguished platform within the fields of rheumatology and immunology since its inception in 1974. With an impressive impact evidenced by its 2023 rankings—Q1 in Rheumatology and Q2 in both Immunology and Allergy—the journal has secured its position as a vital resource for researchers and practitioners alike. The journal is dedicated to advancing clinical and experimental knowledge in the pathogenesis, diagnosis, and management of rheumatic diseases, providing a rich repository of peer-reviewed articles that drive innovation in treatment protocols and patient care. Although it operates under a subscription model, the journal remains accessible to a broad audience committed to advancing their understanding of these critical areas. Located in Toronto, Canada, it continues to attract contributions from leading experts globally, making it an essential read for anyone keen on staying at the forefront of rheumatological research and practice.

Arthritis & Rheumatology

Elevating Standards in Rheumatology Science
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Egyptian Rheumatologist

Pioneering insights for a healthier future.
Publisher: ELSEVIERISSN: 1110-1164Frequency: 4 issues/year

The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.

Archives of Rheumatology

Advancing knowledge in rheumatology for a healthier future.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Open Access Rheumatology-Research and Reviews

Exploring Innovations in Musculoskeletal and Autoimmune Disorders.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

Journal of Rheumatic Diseases

Fostering collaboration to transform rheumatology insights.
Publisher: KOREAN COLL RHEUMATOLOGYISSN: 2093-940XFrequency: 4 issues/year

Journal of Rheumatic Diseases, published by the Korean College of Rheumatology, stands as a pivotal platform in the field of rheumatology, contributing significantly to the advancement of knowledge and clinical practice since its inception. With an impact factor reflecting its esteemed position in the academic community, this open-access journal promotes accessibility to high-quality research, ensuring that groundbreaking discoveries are reachable to all stakeholders in the realm of rheumatic diseases. The journal has maintained its commitment to quality, evidenced by its ranking in the Q3 category for Rheumatology in 2023, and its presence among the top quartiles of medical research. Focusing on innovative therapeutic approaches, emerging diagnostic techniques, and comprehensive reviews, the Journal of Rheumatic Diseases seeks to foster collaboration and dialogue among researchers, clinicians, and students alike. For accessibility, the journal offers numerous articles since its transition to open access in 2017, thereby facilitating research dissemination across the globe. As it converges over the years from 2019 to 2024, the journal promises to be instrumental in shaping the future of rheumatic disease research, inviting contributions that inspire new frontiers in this essential field.

RHEUMATOLOGY INTERNATIONAL

Empowering researchers and clinicians with vital insights.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Modern Rheumatology

Innovating Insights in Rheumatologic Medicine
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Egyptian Rheumatology and Rehabilitation

Elevating standards in patient care and clinical practice.
Publisher: SPRINGERNATUREISSN: 1110-161XFrequency: 1 issue/year

Egyptian Rheumatology and Rehabilitation is a distinguished open-access journal published by SpringerNature, dedicated to the vital field of rheumatology and rehabilitation. With an E-ISSN of 2090-3235 and a commitment to disseminating high-quality research, this journal serves as a platform for researchers, clinicians, and healthcare professionals to share innovative findings and enhance patient care in musculoskeletal disorders and related conditions. Since its transition to open access in 2013, the journal has prioritized accessibility, allowing a wider audience to engage with groundbreaking studies and clinical insights. By fostering a collaborative environment for knowledge exchange, Egyptian Rheumatology and Rehabilitation plays a crucial role in advancing the understanding of rheumatic diseases and improving rehabilitation strategies. The journal's commitment to quality and relevance in the evolving landscape of rheumatology makes it an invaluable resource for those pursuing excellence in research and practice.

Reumatologia Clinica

Elevating the standard of care in rheumatology.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.